EP3066953B1 - Herstellungsverfahren einer schönheitsmaske auf biozellulosebasis, und entsprechende maske - Google Patents
Herstellungsverfahren einer schönheitsmaske auf biozellulosebasis, und entsprechende maske Download PDFInfo
- Publication number
- EP3066953B1 EP3066953B1 EP16020067.1A EP16020067A EP3066953B1 EP 3066953 B1 EP3066953 B1 EP 3066953B1 EP 16020067 A EP16020067 A EP 16020067A EP 3066953 B1 EP3066953 B1 EP 3066953B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- film
- serum
- bio
- process according
- mask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 22
- 230000003796 beauty Effects 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 239000000758 substrate Substances 0.000 title description 2
- 210000002966 serum Anatomy 0.000 claims description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 239000001913 cellulose Substances 0.000 claims description 14
- 229920002678 cellulose Polymers 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 13
- 239000004952 Polyamide Substances 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 9
- 229920002647 polyamide Polymers 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 229920001340 Microbial cellulose Polymers 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- -1 polypropylene Polymers 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 2
- 244000235858 Acetobacter xylinum Species 0.000 claims description 2
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 235000020415 coconut juice Nutrition 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229920006280 packaging film Polymers 0.000 claims description 2
- 239000012785 packaging film Substances 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920006254 polymer film Polymers 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims 1
- 241001466460 Alveolata Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000001143 conditioned effect Effects 0.000 claims 1
- 239000000490 cosmetic additive Substances 0.000 claims 1
- 229940100524 ethylhexylglycerin Drugs 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 229920005594 polymer fiber Polymers 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 5
- 229920002367 Polyisobutene Polymers 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 229920006037 cross link polymer Polymers 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 229940068977 polysorbate 20 Drugs 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- XEFAJZOBODPHBG-UHFFFAOYSA-N 1-phenoxyethanol Chemical compound CC(O)OC1=CC=CC=C1 XEFAJZOBODPHBG-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002749 Bacterial cellulose Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000005016 bacterial cellulose Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/002—Masks for cosmetic treatment of the face
Definitions
- the present invention relates to the method of manufacturing a beauty mask for cosmetic use using a bio-cellulosic support.
- Bio-cellulose synthesized by bacteria from plant substrate, is known for its regenerative properties and its contribution to the penetration of active ingredients deep into the skin ( Wojciech K. Czaja et al., "The future prospects of microbial cellulose in biomedical applications", Biomacromolecules, Vol 8 No 1, January 2007 ).
- the state of the art shows that masks composed in whole or part of bio-cellulose are used as cosmetic beauty masks.
- packaging can be carried out flat by thermoforming a complex on a plastic support to form a tray.
- the shape of such a package does not guarantee a sufficient maintenance of beauty mask type products, they can move in the tray and lose some of the serum they are impregnated.
- the bio-cellulose sheet because of its high water content (up to 9%), is very exposed to the risk of microbiological contamination, hence the need to add preservatives.
- the applicant company has therefore considered a new solution to overcome the previously mentioned constraints.
- she sought to design a beauty mask from a bio-cellulose film synthesized by fermentation of a coconut water, preferably by Acetobacter Xylinum, sterilized by an effective physicochemical method and covered with porous polymer films. .
- the support thus obtained is cut and folded into pre-established forms and impregnated with a serum, comprising active ingredients and additives whose final quantities are controlled and meet the regulatory requirements, conferring on the final product the properties of a cosmetic product, so that the distribution of it on the support is regular.
- the Applicant has had the idea of a flat packaging method by a thermoformer, provided with a zone sterilized by a laminar flow, using a double aluminum complex to form a peelable bag and without requiring the use of preformed type trays as in the methods described in the aforementioned article.
- This process also makes it possible, by the preparation of a suitable serum, a good distribution of this serum in the bio-cellulose sheet.
- a combination of gelling agents, incorporated in pulverulent or emulsified form, composed of 0.2 to 0.5% of acrylate and 0.7 to 1.5% of polyacrylate was chosen to give the serum a viscosity of between 0, 1 and 30 Pa.s, controlled by a Brookfield viscometer using spindle # 6 at 20 rpm. This viscosity allows the serum to spread relatively uniformly over the surface of the sheet while avoiding the risk of sagging during its deposition on a horizontal film during packaging.
- the bio-cellulose film is protected on one of its faces by a polypropylene non-woven fabric which may comprise up to 2% of dye and on its other side by a polyamide film, which may be larger than the cut of the model to facilitate the handling of the product.
- the biocellulosic support obtained is precut according to models either predefined or defined by the Applicant, in particular for neck and bust forms.
- porous structures of these films and in particular the honeycombed polyamide, promote the diffusion of the serum deposited on their surface in the bio-cellulose sheet.
- a preferential mode of folding in two to four stages, is applied to the support, so that its two apparent faces are covered with polyamide.
- the folds expose a support surface adapted to that of the serum applied to the packaging film, promoting optimal distribution thereof.
- the dose of serum is calibrated to optimize the impregnation of the support and to determine the final amount of active mask, to comply with current regulations.
- the serum may contain, typically in a proportion of between 10 and 45% of moisturizing agents, preferably in the form of vegetable glycerine up to 30% supplemented with 0 to 15% of polysaccharides.
- moisturizing agents preferably in the form of vegetable glycerine up to 30% supplemented with 0 to 15% of polysaccharides.
- Different actives can be added depending on the expected cosmetic effects such as aloe vera, sodium hyaluronate, marine collagen or any other well-known ingredient of those skilled in the art in amounts usually used.
- the serum contains, moreover, preservatives sufficiently effective to ensure both the protection of the serum and the bio-cellulosic carrier, while limiting undesirable effects.
- preservatives sufficiently effective to ensure both the protection of the serum and the bio-cellulosic carrier, while limiting undesirable effects.
- Any preservative system well known to those skilled in the art may be used, more particularly, a solution chosen will be the use of phenoxyethanol of 0.3% to 1% coupled with Pentylene glycol of 0.2% to 2%. % and Ethylhexyl glycerine from 0.05% to 1.5%.
- Mask models are given as examples of achievements and are available in several sizes adapted to the morphology of the user.
- a bust model is folded by a folding of its upper ends (2) in three folds (3), (5) and (4).
- the neck mask ( Figure 2A ), rectangular cut with two slots to facilitate anatomical adaptation, is folded into three thicknesses so that one of the two side panels is folded over that of the middle before the second side panel is folded over the together.
- a defined dose of serum is deposited on a multilayer heat-shrinkable flexible horizontal film (6), typically composed of polyethylene terephthalate, aluminum and polyethylene, a packaging article usually used for the manufacture of cosmetic bags.
- the bio-cellulosic support composed of a bio-cellulosic sheet (7) covered with a polyamide film (8) and a nonwoven film (10) ( figure 3B ), cut (11) and folded (12), is affixed so that only the polyamide coating (8) is in contact with the serum (9).
- a second calibrated dose of the serum (9) is applied to the support (12) before a second aluminum film (6) covers the assembly.
- a thermal welding carried out by a thermoformer specially designed for this purpose, seals the packaging around the bio-cellulosic mask, forming a peelable bag whose opening is facilitated by a corner leaving part of the two non-welded films.
- the serum (9) will be deposited on only one side of the support (11), preferably that covered with polyamide (8).
- the polyamide (8) may be replaced by a non-woven fabric (10), similar to that already covering the first face of the sheet (10) and capable of protruding from the biocellulose support (11) or (12).
- the composition of the serum (9) will then be adapted to also allow a good diffusion in the mass of the support (12).
- the method is not limited to the simple steps mentioned above, and given by way of illustration of the embodiments.
Claims (9)
- Verfahren zur Herstellung kosmetischer Masken, getränkt mit einem Serum, dessen Viskosität zwischen 0,1 und 30 Pa.s liegt, dadurch gekennzeichnet, dass es:- als Träger ein sterilisiertes Biozellulose Blatt verwendet (7), das auf beiden Seiten mit porösen Polymerfolien (8 und 10) bedeckt ist,- Aufbringung des Serums (9) in zwei Stufen, wobei zunächst eine definierte Menge auf einer flexiblen heißsiegelbaren Verpackung (6) aufgebracht wird, und danach der Biozelluloseträger (7) darüber gelegt wird. In der Folge wird eine zweite Dosis Serum auf die Oberseite des Biozelluloseträgers (7) dosiert,- mit einer zweiten flexiblen verschließbaren Verpackung (6) versehen wird, die die Biozellulose samt Serum überdeckt und dann mit der ersten verschließbaren Verpackung (6) mittels einer Tiefziehmaschine verschweißt wird, wodurch ein peelfähiger Beutel entsteht, der das Produkt enthält.
- Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß das verwendete Biozellulose Blatt (7) durch Fermentation von Kokoswasser mit Acetobacter Xylinum hergestellt wird.
- Verfahren nach Ansprüchen 1 oder 2, dadurch gekennzeichnet, daß das Biozellulose Blatt (7) durch mindestens eine thermische Behandlung bei 125 ° C, gefolgt von einer Ionisierung von 5 kGy im Inneren, sterilisiert wird.
- Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das Biozellulose Blatt (7) vorgeschnitten und gefaltet (12) in Originalformen anatomisch an den Hals oder die Brust angepasst ist.
- Verfahren, nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Polymerfaserfolien aus einer einseitig gewebten Polypropylen Folie (8) und einer wabenförmigen Polyamid Folie oder einer zweiten Folie bestehend aus Polypropylen-Vliesstoff (10) auf der anderen Seite. Der Vliesstoff kann eine ausreichende Menge an Farbstoff aufweisen, um dem Endprodukt eine charakteristische Farbe zu verleihen.
- Verfahren nach den vorhergehenden Ansprüchen, dadurch gekennzeichnet, daß die Viskosität des Serums (9) durch eine Kombination von 0,2% bis 0,5% Acrylat und 0,7% bis 1,5% Polyacrylat gewährleistet ist.
- Verfahren nach den vorhergehenden Ansprüchen, dadurch gekennzeichnet, dass das verwendete Serum (9) einen oder mehrere kosmetische Zusätze enthält, wie:- Ein oder mehrere Konservierungsmittel, um die Biostabilität des Endprodukts zu gewährleisten.- Ein oder mehrere feuchtigkeitsspendende Mittel.- Ein oder mehrere Farbstoff(en), Pigment(en) oder Zusatzstoffe(n), um die Farbe des Endprodukts zu ändern.- Ein oder mehrere Duftstoffe(n), ätherische Öle(n) oder andere riechende Verbindung(en).- Ein oder mehrere, pflanzliche, mineralische, marine oder synthetische Zusatzstoffe, die im kosmetischen Bereich als "wirksam" gelten.
- Verfahren nach Anspruch 7, dadurch gekennzeichnet, daß das Konservierungssystem aus einer Kombination von 0,3% bis 1% Phenoxyethanol von 0,2% bis 2% Pentylenglykol und 0,05% bis 1,5% von Ethylhexylglycerin besteht.
- Verfahren nach Anspruch 7, dadurch gekennzeichnet, dass das feuchtigkeitsspendende Mittel aus 10% bis 30% pflanzlichem Glycerin und 0 bis 15% eines Polysaccharids besteht.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1500453A FR3033479B1 (fr) | 2015-03-09 | 2015-03-09 | Procede de fabrication d'un masque de beaute a support bio-cellulosique et masque associe |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1500453 Previously-Filed-Application | 2015-03-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3066953A1 EP3066953A1 (de) | 2016-09-14 |
EP3066953B1 true EP3066953B1 (de) | 2018-08-01 |
Family
ID=53269606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16020067.1A Active EP3066953B1 (de) | 2015-03-09 | 2016-03-04 | Herstellungsverfahren einer schönheitsmaske auf biozellulosebasis, und entsprechende maske |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3066953B1 (de) |
FR (1) | FR3033479B1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI663987B (zh) * | 2016-05-17 | 2019-07-01 | 大江生醫股份有限公司 | 功能性生物纖維膜之製備方法及功能性生物纖維面膜 |
US20180325243A1 (en) * | 2017-05-11 | 2018-11-15 | Nichiei Co., Ltd. | Facial pad |
CN110101595B (zh) * | 2019-06-20 | 2022-04-29 | 福清市火麒麟食用菌技术开发有限公司 | 一种绣球菌纤维素面膜的制备方法 |
FR3100109B1 (fr) * | 2019-09-03 | 2021-09-10 | Oreal | Dispositif d’application d’une composition cosmétique |
WO2021074837A1 (ru) * | 2019-10-15 | 2021-04-22 | Товарыство З Обмэжэною Видповидальнистю "Инстытут Гиалуаль" | Комплект одноразовых пленочных изделий, диспенсерная система для дозирования и способ выполнения процедуры |
CN114159369A (zh) * | 2021-12-10 | 2022-03-11 | 江苏普罗诺生物科技有限公司 | 一种蓝铜胜肽抗皱修护精华面膜 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6702792B2 (en) * | 2002-07-18 | 2004-03-09 | Kenji Nakamura | Face mask having excellent usability |
TW201038227A (en) * | 2009-01-29 | 2010-11-01 | Johnson & Johnson Consumer Companies Inc | Facial treatment mask comprising an isolation layer |
JP6116904B2 (ja) * | 2009-11-27 | 2017-04-19 | ロレアル | 美容シート包装体 |
KR102088350B1 (ko) * | 2010-10-26 | 2020-03-12 | (주)아모레퍼시픽 | 화장용 바이오셀룰로오스 마스크팩 시트 및 이의 제조방법 |
-
2015
- 2015-03-09 FR FR1500453A patent/FR3033479B1/fr active Active
-
2016
- 2016-03-04 EP EP16020067.1A patent/EP3066953B1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP3066953A1 (de) | 2016-09-14 |
FR3033479B1 (fr) | 2018-04-13 |
FR3033479A1 (fr) | 2016-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3066953B1 (de) | Herstellungsverfahren einer schönheitsmaske auf biozellulosebasis, und entsprechende maske | |
EP0976382B1 (de) | Kosmetisches oder dermopharmazeutisches Pflaster | |
CA2228731C (fr) | Gel a activite physique antimicrobienne pour produits cosmetiques | |
CA2023127C (fr) | Film composite pour traitement de surface et procedes de fabrication correspondants | |
CN103789109B (zh) | 一种皮肤清洁皂及其制造方法 | |
FR2871685A1 (fr) | Procede de rasage avec un film anhydre ; utilisation d'un film anhydre pour la preparation d'un produit de rasage ; kits de rasage | |
JP6116904B2 (ja) | 美容シート包装体 | |
CN104073000B (zh) | 一种可食性液体丝胶保鲜膜及其制备工艺 | |
EP0976396A1 (de) | Kosmetisches oder Pharmazeutisches Pflaster und Verpackung | |
JP6006478B2 (ja) | 皮膚血行促進化粧料 | |
CN104982950A (zh) | 一种滋阴润燥奶香鸡肉排及其制备方法 | |
WO2018112857A1 (zh) | 一种补水护肤乳液 | |
CN104546514B (zh) | 一种水凝胶微胶囊型护发精华 | |
JP7269855B2 (ja) | ジェルシートマスク | |
CN106214557A (zh) | 纯天然洗发水的制备方法 | |
CN104921170A (zh) | 一种舒肝降压五香鸡排及其制备方法 | |
CN104970984A (zh) | 天然果酸营养面膜 | |
WO2014006983A1 (ja) | 育毛剤組成物 | |
KR102481106B1 (ko) | 비즈 왁스를 유효 성분으로 포함하며, 방수 효과를 높인 천연 코팅 조성물 및 이를 포함하는 천연 포장지 | |
KR101779824B1 (ko) | 기능성 물질을 포함하는 천연 유래 다당류 마이크로 섬유 제조 방법 | |
CN105341728A (zh) | 一种巧克力养阴解郁鸡肉排及其制备方法 | |
WO2018112858A1 (zh) | 一种植物提取物乳液 | |
WO2005092299A1 (fr) | Patch d’amorolfine pour le traitement de l’onychomycose | |
CN104921136A (zh) | 一种竹香悦心桂花鸡排及其制备方法 | |
JP2016041036A (ja) | 粉わさび包装体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170313 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180313 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1023283 Country of ref document: AT Kind code of ref document: T Effective date: 20180815 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016004318 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180801 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1023283 Country of ref document: AT Kind code of ref document: T Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181101 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181102 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181201 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016004318 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190304 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190304 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181201 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200304 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200304 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20160304 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180801 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230322 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230323 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240321 Year of fee payment: 9 |